MétaCan
Menu
Back to cohort

Anemia and FOLFOX chemotherapy for colorectal carcinoma

2005· article· en· W2339055365 on OpenAlexaffabout
S G Taylor, Cheryl Ho, F. Hu, Jeff Barnett, B. Melosky

Bibliographic record

VenueJournal of Clinical Oncology · 2005
Typearticle
Languageen
FieldMedicine
TopicErythropoietin and Anemia Treatment
Canadian institutionsBC Cancer Agency
Fundersnot available
KeywordsMedicineFOLFOXAnemiaColorectal cancerOxaliplatinInternal medicineChemotherapyOncologyCancerGastroenterologySurgery

Abstract

fetched live from OpenAlex

3684 Background: Advanced cancer is frequently associated with anemia which can significantly contribute to overall morbidity in those patients. Anemia has also been associated as a prognostic factor in tumors such as lung, ovarian and head and neck. However research of anemia in colorectal cancer is more limited and mostly refers to treatments with conventional protocols involving 5-FU plus leucovorin but there has been not data regarding the incidence of anemia in more recent therapies such as FOLFOX 6. This retrospective study will determine the prevalence and degree of anemia in patients with metastatic colorectal carcinoma being treated with oxaliplatin based chemotherapy. Methods: A retrospective chart review was performed identifying all patients treated for colorectal carcinoma with first or second line FOLFOX 6 chemotherapy in 2003 at the four British Columbia Cancer Agency cancer centres in British Columbia Canada. Baseline hemoglobin and all hemoglobin levels while on chemotherapy and including two weeks after finishing chemotherapy were selected. Results: 183 patients received FOLFOX chemotherapy in 2003, of which 173 had baseline Hgb available. Mean Hgb at baseline was 124 g/L and 64% (110/173) of patients had a hemoglobin level greater than 120 g/L Mean number of cycles delivered was seven. During chemotherapy, 63% (115/183) of patients had a Hgb level of less than or equal to 120 g/L. However 22% (41/183) patients had documented hemoglobin less than or equal to 100 g/L. Only 14% (26/183) had hemoglobin levels less than or equal to 90 g/L where one may intervene with blood transfusion. Conclusion: Patients with metastatic colorectal cancer being treated with oxaliplatin chemotherapy have a high rate of mild anemia but 22% may require anemia management and 14% may need to be transfused if early intervention is not possible. Its believe that this information may help to anticipate anemia management in this type of patients. No significant financial relationships to disclose.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.042
Threshold uncertainty score0.084

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.081
GPT teacher head0.453
Teacher spread0.372 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2005
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicErythropoietin and Anemia TreatmentFrench-language works237,207